Sharon Bio-Medicine Ltd-$ (Delisted) share news and announcements

BSE: 532908Pharmaceuticals & Biotechnology

Last traded ₹3.30 on 28 Mar 2019

Delisted on 20 Feb 2024.

Sharon Bio-Medicine Ltd-$ share news and announcements

831 announcements, routine notices left out, newest first. Page 8 of 17.

Jan 2018
- 19 Jan · Shareholding for the Period Ended December 31, 2017
  Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
- 19 Jan
  Statement of Investor Compliance for the Quarter ended 31st December,2017 (opens in a new tab)
- 5 Jan · Updates
  Submission of Resolution plan to NCLT on January 04, 2018. (opens in a new tab)
- 5 Jan · Updates
  Submission of Resolution plan to NCLT on January 04, 2018. (opens in a new tab)
Dec 2017
- 27 Dec · Legal
  Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Financial results not submitted as per Ind-AS format. -4. Reconciliation of profit and loss not submitted. -5. Reconciliation of Equity not submitted The response of the Company is enclosed. (opens in a new tab)
- 11 Dec · Legal
  Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Financial results not submitted as per Ind-AS format. -4. Reconciliation of profit and loss not submitted. -5. Reconciliation of Equity not submitted The response of the Company is awaited.
- 8 Dec · Results
  Financial Results for the year ended 31st March 2017 (opens in a new tab)
- 8 Dec · Results
  Financial results for the period ended 31-Mar-2017. (opens in a new tab)
- 1 Dec · Board meeting
  Will consider the Audited Financial Results for the Quarter and Year ended on March 31, 2017. (opens in a new tab)
- 1 Dec · Updates
  Notice for Financial Results for the Quarter ended on March 31st, 2017. (opens in a new tab)
- 1 Dec · Updates
  Notice for Financial Results for the Quarter ended on March 31st, 2017. (opens in a new tab)
Oct 2017
- 27 Oct
  Compliance Certificate for the period ended 30th September, 2017 (opens in a new tab)
- 25 Oct
  Regulation 40(9) of the SEBI (LODR) Regulation 2015, the Certificate for the Half year ended on 30th September, 2017 (opens in a new tab)
- 18 Oct
  Statement Of Investor Complaints For The Quarter Ended 30Th September, 2017 (opens in a new tab)
- 17 Oct · Shareholding for the Period Ended September 30, 2017
  Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....
- 13 Oct · Management
  Appointment of Secretarial and Cost Auditor (opens in a new tab)
- 13 Oct · Updates
  Appointment of Secretarial and Cost Auditor (opens in a new tab)
- 9 Oct · Updates
  Intimation for extension of CIRP Process for 90 days with effect from October 08, 2017 (opens in a new tab)
- 9 Oct · Updates
  This is to inform you that as per section 12(2) of Insolvency and Bankruptcy code, 2016 company have been granted an extension of 90 days for completion of Insolvency Resolution Process .... (opens in a new tab)
Sep 2017
- 26 Sep · Meeting
  Intimation for Extension of Annual General Meeting(AGM) (opens in a new tab)
- 26 Sep · Updates
  Intimation for Extension of Annual General Meeting(AGM) (opens in a new tab)
- 12 Sep · Legal
  Clarification is enclosed. (opens in a new tab)
- 12 Sep · Legal
  Significant increase in price has been observed in Sharon Bio-Medicine Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sharon Bio-Medicine Limited has submitted their response. (opens in a new tab)
  The exchange asked on 11 Sep 2017
- 12 Sep · Legal
  Exchange has sought clarification from Sharon Bio-Medicine Ltd on September 12, 2017, with reference to increase in Price. The reply is awaited.
Jul 2017
- 20 Jul · Shareholding for the Period Ended June 30, 2017
  Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....
- 19 Jul
  Statement Of Investor Complaints For The Quarter Ended 30Th June, 2017 (opens in a new tab)
May 2017
- 26 May · Updates
  Financial results for the year ended March 31, 2017. (opens in a new tab)
- 26 May · Updates
  IRP Intimation Financial Results 31st March, 2017 (opens in a new tab)
- 6 May · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBICAP Trustee Company Ltd (opens in a new tab)
Apr 2017
- 28 Apr
  Regulation 40(9) of the SEBI (Listing Obligation & Disclosure Requirements) Regulation,2015. (opens in a new tab)
- 27 Apr · Updates
  Intimation of initiation of Corporate Insolvency Resolution Process (CIRP) and appointment of Interim Resolution Professional (IRP). (opens in a new tab)
- 27 Apr · Updates
  Intimation of initiation of Corporate Insolvency Resolution Process (CIRP) and appointment of Interim Resolution Professional (IRP). (opens in a new tab)
- 25 Apr · Board meeting
  Board of Directors of the Company at its meeting held on April 24, 2017 has took note of the following : Mr. Harish Palecanda and Dr. Nivedita Patil has tendered their resignation as an Independent Directors on the Board of the Company with effect from April 01, 2017. (opens in a new tab)
- 25 Apr · Board meeting
  Resignation of Mr. Harish Palecanda & Dr. Nivedita Patil as independent directors w.e.f 01 April,2017. (opens in a new tab)
- 21 Apr · Shareholding for the Period Ended March 31, 2017
  Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
- 21 Apr
  Compliance Certificate for the quarter ended 31st March, 2017 (opens in a new tab)
- 20 Apr
  STATEMENT OF INVESTOR COMPLAINTS FOR THE QUARTER ENDED 31ST MARCH, 2017. (opens in a new tab)
- 13 Apr · Disclosure
  SBICAP Trustee Company Ltd. has submitted to the Exchange a copy of disclosure under Regulation 30(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 12 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBICAP Trustee Company Ltd (opens in a new tab)
Mar 2017